Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Market Cap	520.67B +33.3%
Revenue (ttm)	167.47B +3.7%
Net Income	1.63B -86.2%
EPS	21.86 -86.2%
Shares Out	74.34M
PE Ratio	320.41
Forward PE	43.59
Dividend	106.00 (1.51%)
Ex-Dividend Date	Dec 29, 2026

Volume	287,300
Open	6,975.00
Previous Close	6,978.00
Day's Range	6,906.00 - 7,021.00
52-Week Range	5,030.00 - 7,388.00
Beta	0.20
Analysts	Hold
Price Target	5,521.25 (-21.17%)
Earnings Date	Nov 10, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sh...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1886
• Employees: 3,731
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4967

Financial Performance

In 2025, Kobayashi Pharmaceutical's revenue was 165.74 billion, an increase of 0.09% compared to the previous year's 165.60 billion. Earnings were 3.66 billion, a decrease of -63.68%.

Analyst Summary

According to 8 analysts, the average rating for 4967 stock is "Hold." The 12-month stock price target is ¥5,521, which is a decrease of -21.17% from the latest price.

Price Target

¥5,521

(-21.17% downside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 29, 2026

Data Sources Report a data error